Aryl Butenes Active Against K562 Cells and Lacking Tyrosinase Inhibitory Activity as New Leads in the Treatment of Leukemia
Mini-Reviews in Medicinal Chemistry - United Arab Emirates
doi 10.2174/1389557517666170208142254
Full Text
Open PDFAbstract
Available in full text
Date
August 8, 2018
Authors
Publisher
Bentham Science Publishers Ltd.